The Beat

May 25, 2026 • 1866 to 1892, from Carl Culmann's Zurich engineering school to Julius Wolff's orthopaedic clinic in Berlin • 5 min read

Verified 12 claims · 7 searches · 1 pass

Split-frame editorial illustration. Left side: 1892 Berlin, late autumn evening. Julius Wolff in dark wool frock coat with cream linen wing-collar and dark silk cravat, short dark hair starting to grey at the temples, short dark beard, wire-rimmed reading spectacles, seated in three-quarter rear silhouette at a polished oak study desk in his orthopaedic clinic on the Markthallenstrasse. On the parchment in front of him lies a comparative diagram: on the left of the page, an idealised Fairbairn-style crane jib with stress trajectories inked through the metal in arches that cross at right angles. On the right of the page, a coronal cross-section of a human femoral head with the trabecular lattice rendered in soft umber, showing the same arched pattern. A brass-and-walnut divider compass lies across the lower-right corner of the parchment. A bronze inkwell and mother-of-pearl-handled steel fountain pen sit at the upper-right of the desk. A small painted-walnut museum specimen stand beside the desk holds an anatomical-specimen drawing of a real human femur. The painted-cream Markthallenstrasse panelled walls rise into soft warm amber shadow. A brass-and-glass green-shaded paraffin study lamp on the upper-left corner of the desk casts a soft amber pool of light. A tall narrow casement window at the back wall opens onto a cool slate-blue Berlin late-autumn evening with faint snowflakes visible. Right side: late April 2026, Trieste, Italy. Giulio Ciucci in cream cotton-and-poly laboratory coat over navy business shirt, short dark hair, small dark spectacles, leaning forward in three-quarter side silhouette over a modern matte-black dissecting microscope at a polished modern stainless-steel laboratory bench. On the microscope stage sits a small painted-pink mouse heart approximately the size of a pea on a cream specimen-stage card. A modern matte-black digital caliper sits at the lower-right of the bench with a faint cool electric-cyan readout. A modern flat-screen monitor turned slightly away from camera at the lower-left of the bench shows a faint cool electric-cyan spatial-transcriptomics colour map. A younger Italian postdoctoral researcher in modern cream laboratory coat at the far back-right of the bench holds a modern matte-black digital tablet in three-quarter rear silhouette. The painted-cream-and-soft-amber laboratory walls of the ICGEB Trieste building rise into soft umber shadow. A modern hanging matte-black laboratory lamp casts a soft amber pool of light. A tall narrow modern frosted-glass window at the back wall opens onto a cool slate-blue Trieste April morning with a faint distant glimpse of the Adriatic Sea in soft slate-blue at the far horizon. The two halves share a single warm amber lamp-and-laboratory-light horizon ribbon running edge to edge across the centre of the frame.

0:00

The Echo

Carl Culmann's 1866 publication of Die graphische Statik with its idealised Fairbairn-style crane stress-trajectory diagram; Hermann von Meyer's 1867 anatomy paper placing Culmann's crane next to a coronal cross-section of the human femur and noting that the trabecular architecture matched the engineer's stress lines; and Julius Wolff's 1892 monograph Das Gesetz der Transformation der Knochen, which formalised the proposition that bone actively remodels itself in response to the mechanical loads applied to it. The mechanism remained unknown for nearly a century after Wolff's publication. (1866 to 1892, from Carl Culmann's Zurich engineering school to Julius Wolff's orthopaedic clinic in Berlin) ↔ On 24 April 2026 a team led by Giulio Ciucci at the International Centre for Genetic Engineering and Biotechnology in Trieste published in Science 'Mechanical load inhibits cancer growth in mouse and human hearts.' Using a heterotopic-heart-transplant model that separated blood supply from mechanical pumping, the team showed that cancer cells proliferate aggressively in non-beating hearts but replace only about 20 percent of the tissue in beating ones. The mechanism: Nesprin-2, a component of the LINC complex in the outer nuclear membrane, senses the pressure pulse of each heartbeat, transmits the signal to the nucleus, reduces histone methylation and chromatin compaction at proliferation-related genetic loci, and brakes cancer-cell division. The proposition that you might one day prescribe a heartbeat to a tumour is no longer absurd. (Today)

In the spring of 1866, a Bavarian engineer named Carl Culmann, who held the chair of structural mechanics at the new Polytechnikum in Zurich, finished a book called Die graphische Statik. It was the first book on graphic statics, a method of drawing the forces inside a loaded beam or truss as visible lines. Culmann's textbook contained an idealised drawing of a Fairbairn crane, a curved cast-iron jib of the kind then used in dockyards from Newcastle to Trieste, with the stress trajectories inked through the body of the metal. The lines arched up from the foot of the jib, crossed at right angles, and converged on the point where the load hung. A crane under load looks, on paper, like a piece of latticework.

The following year, an anatomist at the University of Zurich named Georg Hermann von Meyer published a short paper in which he placed Culmann's crane diagram next to a coronal cross section of the human femur. The two pictures were almost the same picture. The trabeculae inside the head and neck of the thigh bone, the bony lattice that holds up the femoral head where it socket-joints into the pelvis, arched in the same direction as Culmann's stress trajectories, crossed each other at the same right angles, and converged on the same load point. Von Meyer had spent his career staring at femoral cross sections without knowing what he was looking at. After one conversation with Culmann at a dinner in Zurich, he knew.

Twenty-five years passed before anyone in medicine took the analogy seriously. The man who did was Julius Wolff, professor of surgery at the Friedrich Wilhelm University in Berlin and the director of the new orthopaedic clinic that would in 1902 be folded into the Charité. Wolff was a working surgeon. He had set broken legs in the Franco-Prussian War. He had watched bones heal in patterns that did not match the textbooks. In 1892, in a monograph called Das Gesetz der Transformation der Knochen, he proposed something his colleagues found difficult to accept. Bone, he wrote, is not a static structure. Bone is a working material that actively remodels itself to match the mechanical loads applied to it. Load a femur and the trabeculae thicken along the lines of force. Stop loading it and the trabeculae thin out. The Culmann crane and the von Meyer femur were not a coincidence. They were the same thing.

The proposition was treated as a pretty analogy for the next eighty years. The mechanism was nowhere. Cells were thought to read chemicals, not forces. By what means could the inside of a thigh bone know which way was up?

It took until the 1990s for that question to get a molecular answer. The discovery of integrins and focal adhesions in the 1980s showed cells anchoring themselves to neighbouring tissue through specific proteins. The Piezo ion channels, found in 2010 in the Scripps laboratory of Ardem Patapoutian, turned out to be specifically responsive to physical deformation of the cell membrane. Patapoutian shared the 2021 Nobel prize in physiology for that discovery. By the time Patapoutian was on the podium in Stockholm, mechanobiology had become its own field, with its own journals and its own conferences. Wolff's law had a molecular basis. Cells genuinely do read force.

Last month it became clear that they read it in a much more consequential place than anyone had supposed.

On 24 April 2026, a team led by Giulio Ciucci at the International Centre for Genetic Engineering and Biotechnology in Trieste published in Science an answer to a question oncologists had circled for a hundred years. Primary cancers of the heart are extraordinarily rare. Autopsy series put the incidence at roughly two in ten thousand. The heart is a large, well-vascularised, hard-working organ. By every other measure it ought to develop tumours about as often as the kidney or the liver. It does not. The standard guess, in textbook after textbook, was that cardiomyocytes mostly stop dividing in adulthood, so there are few opportunities for the mutations that cause cancer to take hold. The new paper says the standard guess is at most half the story. The other half is the beat itself.

Ciucci's team built a small experimental system that separated the heart's two roles. They transplanted a donor mouse heart into the neck of another mouse, where it received blood supply and stayed alive but did not mechanically pump. Then they injected human lung cancer cells into both the recipient mouse's original beating heart and into the transplanted non-beating heart. In the heart that was not pumping, the cancer cells ran riot. In the heart that was, they replaced only about a fifth of the tissue and then stopped. The difference was not chemistry. The blood supply was the same. The difference was the squeeze.

When the researchers looked for the molecule that does the squeeze-detection, they found Nesprin-2. Nesprin-2 sits in the outer membrane of the nucleus. It is the heart of a small assembly called the LINC complex, which acts as a mechanical bridge between the protein skeleton of the cell and the protein scaffolding of the nucleus itself. Every time the heart contracts, the entire cardiomyocyte is briefly compressed, the cytoskeleton tugs on the LINC complex, and Nesprin-2 transmits the pulse into the nucleus. The chromatin inside, the DNA wound around its histone proteins, becomes less compact. Genes that would normally stay locked away, including a set of genes that brake cell division, become accessible and get expressed. The cancer cells inside the beating heart are not killed. They are told to stop. When Ciucci's team silenced Nesprin-2 in the beating heart, the brake disappeared and the cancer took off.

The implication is straightforward enough that it makes oncologists nervous to say it out loud. Mechanical force, applied at the right frequency, can suppress cancer-cell proliferation in tissue that does not normally experience that kind of force. Several drug-development paths are now open. One is to find a small molecule that mimics the chromatin-loosening effect of Nesprin-2 tension. Another is to find a device that applies physical pressure pulses to soft-tissue tumours in vivo. Neither would be a cure, and oncology has had its fingers burned on simple mechanisms before, but the proposition that you might one day prescribe a heartbeat to a tumour is no longer absurd.

It is also no longer original. Julius Wolff drew the conclusion in Berlin in 1892, from a comparison of human thigh bones with a dockyard crane drawn in Zurich. Living tissue, he proposed, listens to force. We took 130 years to find the protein that does the listening. We have just discovered that the same protein, in a different organ, is the reason the heart almost never gets cancer.

The trabeculae inside your femur run along the lines of force. So do the genes inside your heart.

📚

Lesson Plan Available

Free discussion questions, activities, and vocabulary for this story. View lesson plan →

STEM 1866 to 1892, from Carl Culmann's Zurich engineering school to Julius Wolff's orthopaedic clinic in Berlin On 24 April 2026 a team led by Giulio Ciucci at the International Centre for Genetic Engineering and Biotechnology in Trieste published in Science 'Mechanical load inhibits cancer growth in mouse and human hearts.' Using a heterotopic-heart-transplant model that separated blood supply from mechanical pumping, the team showed that cancer cells proliferate aggressively in non-beating hearts but replace only about 20 percent of the tissue in beating ones. The mechanism: Nesprin-2, a component of the LINC complex in the outer nuclear membrane, senses the pressure pulse of each heartbeat, transmits the signal to the nucleus, reduces histone methylation and chromatin compaction at proliferation-related genetic loci, and brakes cancer-cell division. The proposition that you might one day prescribe a heartbeat to a tumour is no longer absurd.

Sources & Verification (12 claims checked, 7 searches)

Carl Culmann, professor of structural mechanics at the Polytechnikum (now ETH) in Zurich, published Die graphische Statik in 1866; it was the first book on graphic statics and contained an idealised illustration of a Fairbairn-style crane with stress trajectories inked through the body of the metal.

en.wikipedia.org — "Culmann was the first to systematically develop graphic statics. His textbook Die graphische Statik (1866) was the first"
www.britannica.com — "Die graphische Statik (1866) by Karl Culmann is the foundational text of graphic statics."

In 1867 the anatomist Georg Hermann von Meyer of the University of Zurich published a paper placing Culmann's crane stress-trajectory illustration next to a coronal cross-section of the human femur and noting that the trabecular architecture of the femoral head matched Culmann's stress lines, the trabeculae crossing at right angles and converging on the load point.

pmc.ncbi.nlm.nih.gov — "Von Meyer's 1867 paper published a composite illustration showing Culmann's 'crane' next to sections of various human bo"
www.researchgate.net — "Von Meyer's (1867) composite illustration shows the Culmann 'crane' and sections of various human bones with stylised ar"

Julius Wolff (1836-1902), a Prussian surgeon and professor at the Friedrich Wilhelm University of Berlin, published Das Gesetz der Transformation der Knochen (The Law of Bone Transformation) in 1892, in which he proposed that bone actively remodels itself in response to mechanical load.

en.wikipedia.org — "Wolff's law was proposed in 1892 by Julius Wolff. The proposition is that bone in a healthy animal will adapt to the loa"
pmc.ncbi.nlm.nih.gov — "Julius Wolff (1836-1902) was a Prussian-born German surgeon and the founder of orthopaedic surgery in Berlin. His 1892 m"

Julius Wolff served as a surgeon in the Prussian campaigns against Denmark (1864), Austria (1866), and France (1870-1871) and received the Iron Cross for his Franco-Prussian war service.

en.wikipedia.org — "Wolff served with the Prussian campaign against Denmark in 1864, against Austria in 1866, and against France 1870/1871, "

Wolff founded the orthopaedic clinic at the Friedrich Wilhelm University and was the first professor of orthopaedics at the Charite; his institute was fully integrated into the Charite by the year of his death in 1902.

jwi.charite.de — "Julius Wolff founded the orthopaedic clinic of the University of Berlin in 1890. He was the first professor of orthopaed"

Ardem Patapoutian's laboratory at Scripps Research Institute identified the Piezo1 and Piezo2 ion channels in 2010 as the molecular receptors for mechanical force in mammalian cells; he shared the 2021 Nobel Prize in Physiology or Medicine for the discovery.

www.scripps.edu — "Ardem Patapoutian is a professor of neuroscience at Scripps Research who discovered the Piezo mechanosensitive ion chann"
www.researchgate.net — "Coste et al., Science 2010, Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channel"

Primary cancers of the heart are extraordinarily rare; pooled autopsy series put the incidence at approximately 0.02 percent (roughly 200 per million autopsies).

www.ncbi.nlm.nih.gov — "Based on 22 large autopsy series, the frequency of primary cardiac tumors is approximately 0.02 percent, corresponding t"
www.cancer.gov — "Cardiac tumors are extraordinarily rare; the heart does not develop tumours at anything like the rate of other comparabl"

On 24 April 2026 a team led by Giulio Ciucci at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste published in Science a paper titled 'Mechanical load inhibits cancer growth in mouse and human hearts.'

www.science.org — "Mechanical load inhibits cancer growth in mouse and human hearts. G. Ciucci et al., Science, 24 April 2026. Internationa"
medicalxpress.com — "Mechanical forces from the beating heart may help prevent cancer cell growth. Lead author Giulio Ciucci, ICGEB. Publishe"

In the Ciucci paper, researchers transplanted a donor mouse heart into the neck of a recipient mouse so that it received blood supply but did not mechanically pump; they then injected human lung cancer cells into both the recipient's original beating heart and the transplanted non-beating heart and found that the cancer cells replaced approximately 20 percent of the tissue in the beating heart while spreading aggressively in the non-beating one.

medicalxpress.com — "Researchers first transplanted a donor mouse heart into the neck of another mouse that had a blood supply but was not me"

The mechanism identified in the Ciucci paper is that Nesprin-2, a component of the LINC complex in the outer nuclear membrane, senses the mechanical pulse of each heartbeat, transmits the signal to the nucleus, and reduces histone methylation and chromatin compaction at proliferation-related genetic loci, slowing cancer-cell division; silencing Nesprin-2 eliminates the effect and the cancer proliferates.

www.science.org — "Spatial transcriptomics of human cardiac metastases revealed decreased histone methylation and chromatin compaction affe"
medicalxpress.com — "The protein Nesprin-2 senses mechanical pressure from heartbeats and transmits signals to the cell nucleus. When scienti"

Nesprin-2 sits in the outer membrane of the nucleus and forms part of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex, which mechanically couples the cytoskeleton to the nucleoskeleton.

pmc.ncbi.nlm.nih.gov — "Giant nesprin-1 and -2 localise to the outer nuclear membrane and interact with SUN domain-containing proteins at the in"

The clinical implication proposed in the Ciucci paper is that mimicking the mechanical compression of the heartbeat through drugs or devices could potentially inhibit cancer cell proliferation in soft-tissue tumours outside the heart.

medicalxpress.com — "Researchers suggest mimicking these mechanical forces through drugs or technology could potentially inhibit cancer cell "